Home › Compare › YRLLF vs MRK

YRLLF vs MRK: Dividend Comparison 2026

YRLLF yields 45454.55% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 YRLLF wins by $1.8518439162416517e+23M in total portfolio value
10 years
YRLLF
YRLLF
● Live price
45454.55%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.8518439162416517e+23M
Annual income
$184,386,416,447,528,030,000,000,000,000.00
Full YRLLF calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — YRLLF vs MRK

📍 YRLLF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodYRLLFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, YRLLF + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
YRLLF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

YRLLF
Annual income on $10K today (after 15% tax)
$3,863,636.36/yr
After 10yr DRIP, annual income (after tax)
$156,728,453,980,398,820,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, YRLLF beats the other by $156,728,453,980,398,820,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of YRLLF + MRK for your $10,000?

YRLLF: 50%MRK: 50%
100% MRK50/50100% YRLLF
Portfolio after 10yr
$9.259219581208259e+22M
Annual income
$92,193,208,223,764,020,000,000,000,000.00/yr
Blended yield
99.57%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

YRLLF
No analyst data
Altman Z
-221.1
Piotroski
2/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

YRLLF buys
0
MRK buys
0
No recent congressional trades found for YRLLF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricYRLLFMRK
Forward yield45454.55% ✓3.25%
Annual dividend / share$2.00$3.08 ✓
Payout ratio50%42% ✓
1-year div growth0%5.5% ✓
5-year div CAGR0%8.2% ✓
Portfolio after 10y$1.8518439162416517e+23M$30.7K ✓
Annual income after 10y$184,386,416,447,528,030,000,000,000,000.00 ✓$950.29
Total dividends collected$1.851319904100255e+23M$6.1K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: YRLLF vs MRK ($10,000, DRIP)

YearYRLLF PortfolioYRLLF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$4,556,155$4,545,454.55$11,192$351.54+$4.54M → YRLLF
2$1,940,369,795$1,935,494,709.20$12,524$392.70+$1940.36M → YRLLF
3$772,437,161,927$770,360,966,246.63$14,015$438.65+$772437.15M → YRLLF
4$287,435,060,178,011$286,608,552,414,749.56$15,682$489.96+$287435060.16M → YRLLF
5$99,981,569,689,116,400$99,674,014,174,725,920.00$17,547$547.23+$99981569689.10M → YRLLF
6$32,509,470,002,941,550,000$32,402,489,723,374,190,000.00$19,632$611.16+$32509470002941.53M → YRLLF
7$9,881,345,376,928,724,000,000$9,846,560,244,025,577,000,000.00$21,963$682.53+$9881345376928724.00M → YRLLF
8$2,807,666,349,987,340,400,000,000$2,797,093,310,434,026,500,000,000.00$24,571$762.18+$2807666349987340288.00M → YRLLF
9$745,771,193,118,814,000,000,000,000$742,766,990,124,327,600,000,000,000.00$27,486$851.08+$745771193118813978624.00M → YRLLF
10$185,184,391,624,165,170,000,000,000,000$184,386,416,447,528,030,000,000,000,000.00$30,745$950.29+$1.8518439162416517e+23M → YRLLF

YRLLF vs MRK: Complete Analysis 2026

YRLLF — Stock

Global UAV Technologies Ltd. operates as a technology company that offers unmanned aerial vehicle (UAV) services in Canada. It offers aerial surveys, high eye aerial imaging, and UAV regulatory services, as well as UAV-based surface and sub-surface imagery services for various technical fields, including mining and aggregates, agriculture, inspection, and construction surveying. The company was formerly known as Alta Vista Ventures Ltd. and changed its name to Global UAV Technologies Ltd. in May 2017. Global UAV Technologies Ltd. is based in Vancouver, Canada.

Full YRLLF Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this YRLLF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

YRLLF vs SCHDYRLLF vs JEPIYRLLF vs OYRLLF vs KOYRLLF vs MAINYRLLF vs JNJYRLLF vs ABBVYRLLF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.